Effects of Autogenic Inhibition Versus Reciprocal Inhibition in Individuals With Lower Cross Syndrome

ConditionLower Cross Syndrome

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age25-50

SponsorFoundation University Islamabad

About this trial

This study examines the effects of autogenic inhibition (PFS) versus reciprocal inhibition in individuals with lower cross syndrome

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Both Males and Females will be included in our study Age 25-50 years Four positive screening tests (Thomas Test, Abdominal Strength Test, Glutues Maximus Test, Ely's Test) chronic Pain in lower Back Region (>3 on VAS) lasting for more than 2 months

Disqualifiers

Osteoporosis Congenital Hip Dysplasia History of Fracture History of Inflammatory Arthritis Pregnancy

Trial design

Design model

Parallel

Treatments tested in this trial

Autogenic Inhibition (PFS) Group A
Procedure/Surgery
Patient will receive a four-week physiotherapy program with 3 sessions per week. Each session with heat application followed by supervised stretching and strengthening exercises. Participants in group A will receive Autogenic Inhibition (PFS) 10 minutes TENS \& Heating Pad Autogenic Inhibition for 5 sec 5 reps, 5 sec hold,1 set Frequency: 12 sessions for 4 weeks (3 sessions per week and day of rest between sessions) Total Treatment Time 30 minutes each session Strengthening Exercises for Hip and Core Muscles
Reciprocal Inhibition Group B
Procedure/Surgery
Patient will receive a four-week physiotherapy program with 3 sessions per week. Each session with heat application followed by supervised stretching and strengthening exercises. Participants in group B will receive Reciprocal Inhibition 10 minutes TENS \& Heating Pad Inhibition for 5 sec 5 reps,5 sec hold,1 set Frequency: 12 sessions for 4 weeks (3 sessions per week and day of rest between sessions) Total Treatment Time 30 minutes each session Strengthening Exercises for Hip and Core Muscles

Treatment groups

72 Participants

are divided into 2 treatment groups

Group A: Group A:Autogenic Inhibition(PFS)Experimental treatment 1 intervention

Group B: Group B: Reciprocal InhibitionExperimental treatment 1 intervention

Trial outcomes